FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer “On April 18, 2024, the Food and Drug Administration approved alectinib (Alecensa, Genentech, Inc.) for adjuvant treatment following tumor resection in patients with anaplastic...
‘Doctors told me I’d die before I left school’“”If you’re lucky, you have about two years. But you probably won’t live long enough to leave school.” Those were the words Mark Ward says he will never forget hearing from a...
Exercise may reduce heart disease risk by changing how the brain reacts to stress“Physical activity can help reduce the chances of cardiovascular disease by affecting stress responses in the brain, according to a new study. The researchers found that those who met the...
Deaths From Viral Hepatitis Are on the Rise“Viral hepatitis is now the second leading infectious cause of death globally after tuberculosis, the World Health Organization’s report reveals. Viral hepatitis testing and treatment coverage rates have stalled despite...
Radon Gas Exposure May Be Linked to Increased Incidence of Lung Cancer in Nonsmokers“Long-term exposure to radon gas may be associated with a rise in nonsmoking lung cancer cases, according to a recent consumer survey conducted on behalf of The Ohio State University...
Effect of Integrated Naturopathy Interventions on Systemic Inflammatory Markers and Quality of Life in Patients With Active Rheumatoid Arthritis: A Randomized Controlled Trial “Conclusions: The findings of the present study suggest that integrated naturopathy...
Study of Global Lung Cancer Deaths Points to Emerging Trends and Effects on Women “A new study examines the causes of lung and related cancers in the 10 most populous nations, including the U.S. The findings, by researchers at Sylvester Comprehensive Cancer Center,...
Hepatitis C cases dropped in the US. Health officials unsure if it’s a blip or trend“NEW YORK — New U.S. hepatitis C infections dropped slightly in 2022, a surprising improvement after more than a decade of steady increases, federal health officials said...
Health Plans Predict: Implementing Upper Payment Limits May Alter Formularies and Benefit Design But Won’t Reduce Patient Costs Prescription Drug Affordability Board (PDAB) Research Update: The Partnership to Fight Chronic Disease (PFCD) has released a white...
B.C. government makes hepatitis C treatment available to all residents “The B.C. government will now allow anyone living with chronic hepatitis C to access treatment, even in its early stages. “What we hope, of course, is from a health cost perspective that it...
More News and Updates